Rivian Automotive, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Rivian Automotive, Inc. trades at $12.87 (market cap $19.36B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Rivian Automotive, Inc. is far larger — about 10.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rivian Automotive, Inc. for 61 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| RIVN | VIR | |
|---|---|---|
Market Cap | $19.36B | $1.80B |
Volume | 16,483,640 | 1,782,836 |
Sector | Consumer Cyclical | Health |
52-Week High | $22.45 | $11.78 |
52-Week Low | $12.50 | $5.12 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $19.40B | $1.36B |
Signals from Pluang's Aura AI — not financial advice
Rivian Automotive (RIVN) trades at $12.95, down 4.36% amid a bearish technical signal despite beating Q3 2026 delivery estimates with 19,248 vehicles. The company maintains negative profitability with a net income margin of -54.95% but shows improving revenue trends, reaching $5.39 billion in 2025. Cash flow remains negative, though operational losses have narrowed significantly from previous years.
The stock presents a high-risk opportunity with Wall Street consensus leaning bullish (48% buy ratings) and a $16.89 price target, implying potential upside. Key risks include persistent cash burn, intense EV competition, and execution challenges in scaling R2 production and autonomy technology, which are critical for achieving profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →